NDC 50090-0403

Novolin 70/30

Human Insulin

Novolin 70/30 is a Subcutaneous Injection, Suspension in the Human Otc Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Human.

• Product ID: 50090-0403_b8bf85ee-e8f7-4350-bf6a-b5efece7adcc
• NDC: 50090-0403
• Product Type: Human Otc Drug
• Proprietary Name: Novolin 70/30
• Generic Name: Human Insulin
• Dosage Form: Injection, Suspension
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 1991-06-25
• Marketing Category: NDA / NDA
• Application Number: NDA019991
• Labeler Name: A-S Medication Solutions
• Substance Name: INSULIN HUMAN
• Active Ingredient Strength: 100 [USP'U]/mL
• NDC Exclude Flag: E
• Listing Certified Through: 2018-12-31

Packaging

NDC 50090-0403-0

1 VIAL in 1 CARTON (50090-0403-0) > 10 mL in 1 VIAL

• Marketing Start Date: 2014-11-28
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 50090-0403-0 [50090040300]

Novolin 70/30 INJECTION, SUSPENSION

• Marketing Category: NDA
• Application Number: NDA019991
• Product Type: HUMAN OTC DRUG
• Billing Unit: ML
• Marketing Start Date: 2014-11-28
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
INSULIN HUMAN	100 [USP'U]/mL

OpenFDA Data

• SPL SET ID: e825d7e9-467c-4f50-a6d6-f2602449c1de
• Manufacturer:
  • A-S Medication Solutions
• UNII:
  • 1Y17CTI5SR
• RxNorm Concept Unique ID - RxCUI:
  • 311048
  • 213442

NDC Crossover Matching brand name "Novolin 70/30" or generic name "Human Insulin"

NDC	Brand Name	Generic Name
0169-1833	Novolin	Human Insulin
0169-1834	Novolin	Human Insulin
0169-1837	Novolin	Human Insulin
0169-3003	Novolin	Human Insulin
0169-3004	Novolin	Human Insulin
0169-3007	Novolin	Human Insulin
50090-0403	Novolin	Human Insulin
50090-0497	Novolin	Human Insulin
50090-0498	Novolin	Human Insulin
64725-1833	Novolin	Human Insulin
64725-1834	Novolin	Human Insulin
64725-1837	Novolin	Human Insulin
68071-1701	Novolin	Human Insulin